← Leaderboards
Massa J. Shoura
Phinomics Inc.
$2,544,007
Attributed
$2,544,007
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NIH$2,544,007 · 1
By mechanism
R44$2,544,007 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Antibiotics”
- Andrew Tomaras · Forge Therapeutics, Inc.$10,977,909
- Urs Oschner · Crestone, Inc.$8,499,692
- Brian Kane · Spero Therapeutics, Inc.$6,712,318
- M.r.k. (dickon) Alley · An2 Therapeutics, Inc.$4,957,446
- Ralf Lenigk · Ge Medical Systems Information Technologies, Inc$4,211,973
- Robert Pease Smith · Tufts University Boston$3,652,652
Research focus
AntibioticsBiogenesisBioinformaticsAreaBiologicalBiological MarkersBiomarker IdentificationBiophysicsBiopsyBioinformatics PipelineCancer BiomarkersCancer Cell LineCancer DiagnosisCancer DiagnosticsCancer TherapyCell LineCell PhysiologyCellsCircular DnaClia CertifiedCommercializationBladder NeoplasmCopy Number PolymorphismCost Effective
Grant awards (3)
Novel Technologies to Isolate and Analyze Extrachromosomal DNAs for Diagnostic Applications$1,084,044
R44 · FY2025 · GM · contact PI
Novel Technologies to Isolate and Analyze Extrachromosomal DNAs for Diagnostic Applications$1,128,400
R44 · FY2024 · GM · contact PI
Novel Technologies to Isolate and Analyze Extrachromosomal DNAs for Diagnostic Applications$331,563
R44 · FY2023 · GM · contact PI